Insulet (PODD) Interest Coverage Ratio Growth (5y) (2015 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 50.44% |
| Sep 30, 2024 | 31.39% |
| Jun 30, 2024 | 37.87% |
| Mar 31, 2024 | 36.96% |
| Dec 31, 2023 | 46.35% |
| Sep 30, 2023 | 39.35% |
| Jun 30, 2023 | 40.13% |
| Dec 31, 2022 | 91.15% |
| Sep 30, 2022 | -6.23% |
| Dec 31, 2019 | 34.10% |
| Sep 30, 2019 | 31.42% |
| Jun 30, 2019 | 22.41% |
| Mar 31, 2019 | 35.85% |
| Dec 31, 2018 | 117.59% |
| Sep 30, 2018 | 17.42% |
| Dec 31, 2017 | 40.16% |
| Sep 30, 2017 | 17.11% |
| Jun 30, 2017 | 23.59% |
| Mar 31, 2017 | 17.76% |
| Dec 31, 2016 | 22.16% |
| Sep 30, 2016 | 18.26% |
| Jun 30, 2016 | 33.96% |
| Mar 31, 2016 | 2.24% |
| Dec 31, 2015 | -35.79% |
| Sep 30, 2015 | -16.91% |
| Jun 30, 2015 | -11.15% |